Ensure early, targeted therapy. Reduce unnecessary antibiotic use.
Antimicrobial stewardship (AMS) helps hospitals coordinate interventions that support the appropriate use of antibiotics and selection of the ideal drug, dose, duration of therapy and route of administration. Stewardship plays a key role in ensuring early, targeted therapy for patients with critical infections while at the same time reducing unnecessary antibiotic use and lowering hospital costs.
AdvanDx is a key component to AMS because it enables microbiology labs to provide real-time diagnostic support to physicians and pharmacists who in turn can optimize antibiotic therapy and care earlier for patients with bloodstream infections.
Is Your Hospital Ready to Meet Pending Antimicrobial Stewardship Regulations?
By the end of 2017, CMS (Centers for Medicare & Medicaid Services) should have Federal regulations in place that will require U.S. hospitals, critical access hospitals, and long‐term care and nursing home facilities to develop and implement robust antibiotic stewardship programs that adhere to best practices. Similar requirements should be phased in rapidly for other settings, including long‐term acute care hospitals, other post‐acute facilities, ambulatory surgery centers, and dialysis centers. Is your hospital ready?
The AdvanDx Solution
Clinical studies have shown that incorporating PNA FISH into hospitals’ Antimicrobial Stewardship Programs led to 1) shorter times to appropriate therapy, 2) lower mortality rates, 3) shorter lengths of stay (LOS), and 4) real reductions in hospital bed, pharmacy and laboratory costs.1,2 The clinical impact of the PNA FISH test was the ability of the hospital ASP to get early results.
How we serve key stakeholders in Antimicrobial Stewardship
Earlier Antibiotic Decisions